Intracellular amino acid levels are disrupted by GCN2 inhibition in metastatic prostate cancer cell lines, as GCN2 is necessary for transporter gene expression downstream of ATF4 (77). This evidence concerns the gene EIF2AK4 and prostate carcinoma.